inforMED
InjuryLSL

APTIMA COMBO 2 ASSAY

Received Jul 25, 2025 · Event occurred May 30, 2025

Report 2024800-2025-00047 · MDR key 22613141

Device

Generic name

Dna-reagents, Neisseria

Manufacturer

Hologic, Inc.

Catalog number

302661

Lot number

905910

Product problems

  • Imprecise or Erratic Results
  • Imprecise or Erratic Results

Patient

NA · Unknown

  • No Clinical Signs, Symptoms or Conditions
  • No Clinical Signs, Symptoms or Conditions

Narrative

Description of Event or Problem

ON (B)(6) 2025, A CUSTOMER REPORTED TO HOLOGIC THAT THEY RECEIVED DISCREPANT RESULTS USING APTIMA COMBO 2 ASSAY (AC2) WHEN TESTING A SAMPLE ON TWO DIFFERENT PANTHER INSTRUMENTS. ON (B)(6) 2025, SAMPLE ID# (B)(6) WAS TESTED ON (B)(4) USING AC2 MASTER LOT 905910 ON PANTHER INSTRUMENT SERIAL NUMBER (B)(6) AND THE SAMPLE RESULTED CT NEGATIVE & GC NEGATIVE. ON THE SAME DAY, THE CUSTOMER ACCIDENTALLY RETESTED THE SAMPLE ON (B)(4) USING AC2 MASTER LOT 905910 ON PANTHER INSTRUMENT SERIAL NUMBER (B)(6) AND IT RESULTED CT POSITIVE AND GC NEGATIVE. CUSTOMER NOTED THE CT NEGATIVE RESULT WAS AUTOMATICALLY REPORTED TO THE PHYSICIAN/PATIENT. CUSTOMER AMENDED THE CT NEGATIVE RESULT TO POSITIVE. NO PATIENT TREATMENT INFORMATION WAS PROVIDED BY THE CUSTOMER. HOLOGIC HAS NOT LEARNED OF ANY ADVERSE PATIENT OUTCOMES DUE TO THIS EVENT.

Additional Manufacturer Narrative

HOLOGIC TECHNICAL SUPPORT (TS) REVIEWED ALL OF CUSTOMER WORKLISTS AND NOTED NO HARDWARE OR REAGENT PREPARATION ISSUES. HOLOGIC DETERMINED THE MOST LIKELY CAUSE OF THE DISCREPANT CT RESULT IS POTENTIAL SAMPLE MISHANDLING OR LOW TARGET SAMPLE. HOLOGIC PERFORMED A RISK ASSESSMENT AND NOTED NO PRODUCT IMPACT. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.